Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | HMGB1 | P09429 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA6 | P23280 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3624217 | 0.98 | FOLH1 (0.57) | FOLH1ALDH1A1ALOX15TSHRTP53 | |
| SCHEMBL28805448 | 0.98 | FOLH1 (0.57) | FOLH1ALDH1A1ALOX15TSHRTP53 | |
| SCHEMBL27345540 | 0.98 | FOLH1 (0.57) | FOLH1ALDH1A1ALOX15TSHRTP53 | |
| Hydrogen Sulfide SCHEMBL27518474 | 0.98 | FOLH1 (0.57) | FOLH1ALDH1A1ALOX15TSHRTP53 | |
| SCHEMBL27495555 | 0.98 | FOLH1 (0.57) | FOLH1ALDH1A1ALOX15TSHRTP53 | |
| SCHEMBL27334154 | 0.98 | FOLH1 (0.57) | FOLH1ALDH1A1ALOX15TSHRTP53 | |
| Water SCHEMBL28844415 | 0.98 | FOLH1 (0.57) | FOLH1ALDH1A1ALOX15TSHRTP53 | |
| SCHEMBL27690026 | 0.98 | FOLH1 (0.57) | FOLH1ALDH1A1ALOX15TSHRTP53 | |
| SCHEMBL27619745 | 0.96 | FOLH1 (0.55) | FOLH1ALDH1A1ALOX15TSHRTP53 | |
| Methyl Alcohol SCHEMBL27864731 | 0.96 | FOLH1 (0.55) | FOLH1ALDH1A1ALOX15TSHRTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 664 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119822722-A | Anti-cracking plant fiber concrete and preparation method thereof | 中建四局第六建设有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-119735514-A | Preparation method of aminomethylbenzoic acid | 江西道仕化学有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-221514505-U | Production device of p-chloromethyl benzoic acid | 云南衡楚药业有限公司 | 2024-08-13 | — | — | CN | claimed |
| CN-221287872-U | Processing recovery unit of p-chloromethyl benzoic acid | 云南衡楚药业有限公司 | 2024-07-09 | — | — | CN | claimed |
| EP-3169403-B9 | ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES | PROTAGONIST THERAPEUTICS INC (US) | 2024-07-03 | — | — | EP | claimed |
| US-20240199700-A1 | ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES | PROTAGONIST THERAPEUTICS INC (US) | 2024-06-20 | — | — | US | claimed |
| EP-4378536-A2 | ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES | Protagonist Therapeutics, Inc. (US) | 2024-06-05 | — | — | EP | claimed |
| CN-118063472-A | Imidazo [3,4-d ] pyrimidine compound and synthetic method and application thereof | 河北大学 | 2024-05-24 | — | — | CN | claimed |
| EP-3169403-B1 | ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES | PROTAGONIST THERAPEUTICS INC (US) | 2024-02-14 | — | — | EP | claimed |
| US-20230416252-A1 | PROCESS TOWARD THE MANUFACTURE OF (6R,10S)-10-{4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)-PYRIMIDINYL}- 1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15-(METHENO)PYRAZOLO[4,3-B][1,7]DIAZACYCLOTETRADECIN-5(6H)-ONE | JANSSEN PHARMACEUTICA NV (BE) | 2023-12-28 | — | — | US | claimed |
| CN-101328319-A | Water-soluble bridged ring polymethine 3H-indole cyanine dyes ultrasonic synthetic method | UNIV YANSHAN (CN) | 2008-12-24 | — | — | CN | claimed |
| CN-101328318-A | Water-soluble linear polymethine 3H-indole cyanine dyes ultrasonic synthetic method | UNIV YANSHAN (CN) | 2008-12-24 | — | — | CN | claimed |
| CN-101012182-A | Azo monomer and polymer with third order non-linear optical property | UNIV SOOCHOW (CN) | 2007-08-08 | — | — | CN | claimed |
| CN-1975552-A | Third order non-linear optical material monomer, its polymer and production | UNIV SUZHOU (CN) | 2007-06-06 | — | — | CN | claimed |
| CN-1907948-A | Preparation method of 4-chloromethyl benzoic acid t-butyl ester | UNIV TONGJI (CN) | 2007-02-07 | — | — | CN | claimed |
| CN-1282695-C | Flame retardant compositions | CIBA SC HOLDING AG (CH) | 2006-11-01 | — | — | CN | claimed |
| CN-1705705-A | Flame retardant composition | CIBA SC HOLDING AG (CH) | 2005-12-07 | — | — | CN | claimed |
| EP-0884096-B1 | Semipermeable encapsulated membranes with improved acid and base stability process for their manufacture and their use | KOCH MEMBRANE SYSTEMS INC (US) | 2005-09-14 | — | — | EP | claimed |
| CN-1498244-A | Flame retardant compositions | �������⻯ѧƷ�ع�����˾ | 2004-05-19 | — | — | CN | claimed |
| US-6086764-A | Semipermeable encapsulated membranes with improved acid and base stability process for their manufacture and their use | CROSSWINDS, INC. (US) | 2000-07-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199700-A1 | ORAL PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY BOWEL DISEASES | IL23R, IL1RN, VIP | FOLH1 481/4885ALDH1A1 4662/4885ALOX15 917/4885 |
| US-20230416252-A1 | PROCESS TOWARD THE MANUFACTURE OF (6R,10S)-10-{4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)-PYRIMIDINYL}- 1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15-(METHENO)PYRAZOLO[4,3-B][1,7]DIAZACYCLOTETRADECIN-5(6H)-ONE | CYP1B1, AZI2, TET1 | FOLH1 2526/4885ALDH1A1 206/4885ALOX15 250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.